Financials
- Market Capitalization 43.12 M
- Employee 39
- Founded 2015
- CEO Denise Scots-Knight
- Website www.mereobiopharma.com
- Headquarter United Kingdom
- FIGI BBG00KFWZC67
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-10.59
ratio cours/chiffre d'affaires
—
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 4296 | GRCE Grace Therapeutics, Inc. - Common Stock | 2.11 USD | -1.40% | -2.31% | +0.96% | -46.98% | 44.39 M USD | ||
| 4299 | MGX Metagenomi Therapeutics, Inc. - Common Stock | 1.17 USD | +0.86% | -4.10% | -2.50% | -18.75% | 44.20 M USD | ||
| 4333 | CRVO CervoMed Inc. - Common Stock | 2.62 USD | -0.76% | 0.00% | -2.60% | -75.61% | 39.61 M USD | ||
| 4337 | KPTI Karyopharm Therapeutics Inc. - Common Stock | 1.76 USD | -1.68% | -12.00% | -11.11% | -81.74% | 39.92 M USD |